RT @sasurai_NS: cIMPACT-NOW Update 3 When IDH-wildtype diffuse astrocytic glioma has EGFR amplification, Combined whole chromosome 7 agai…
cIMPACT-NOW Update 3 When IDH-wildtype diffuse astrocytic glioma has EGFR amplification, Combined whole chromosome 7 again and whole chromosome 10 loss, and TERT promoter mutation , it is diagnosed with WHO grade Ⅳ #neurosurgery https://t.co/i61Gmt4RzH
cIMPACT-NOW Update 3 IDH wildtype びまん性星細胞腫 の予後を分子診断 ・EGFR増幅 ・染色体7番全長増幅と10番の全長欠失 ・TERT promoter 変異 のいずれかを満たせば WHO grade Ⅳ とすることを提言 #脳外科 https://t.co/ZE4PDKewhx
This adds to the previous cIMPACT 3 update (OA) which termed IDH-wt tumors, whatever the grade "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV". Assuming they can and should be treated as GBM regardless grade
@Vandita27640011 @mlage @MGHNeuroOnc @MGHPathology @neuropathology @CraigHorbinski Actually the field is moving in that direction with the recognition of ‘molecular glioblastoma’ https://t.co/7wiXs90RtX
RT @BSNRTrainees: Remember WHO tumour classification is being continuously updated and we need to understand the changes - 2018 update here…
RT @BSNRTrainees: Remember WHO tumour classification is being continuously updated and we need to understand the changes - 2018 update here…
Remember WHO tumour classification is being continuously updated and we need to understand the changes - 2018 update here: https://t.co/1Z1t7MN5cM @MarionSmits #BSNR2019
RT @mlage: Update 1 https://t.co/gHPtjeksjh Update 2 https://t.co/Mdqme1wZs3 Update 3 https://t.co/9Qfaj4B7Bh Update 4 https://t.co/c62jqda…
RT @mlage: Update 1 https://t.co/gHPtjeksjh Update 2 https://t.co/Mdqme1wZs3 Update 3 https://t.co/9Qfaj4B7Bh Update 4 https://t.co/c62jqda…
RT @esmoriarty01: RT DimitriTrembath: RT mlage: Update 1 https://t.co/HakR1OOC9z Update 2 https://t.co/6N6QAHgTzK Update 3 https://t.co/OGt…
RT @mlage: Update 1 https://t.co/gHPtjeksjh Update 2 https://t.co/Mdqme1wZs3 Update 3 https://t.co/9Qfaj4B7Bh Update 4 https://t.co/c62jqda…
RT DimitriTrembath: RT mlage: Update 1 https://t.co/HakR1OOC9z Update 2 https://t.co/6N6QAHgTzK Update 3 https://t.co/OGt9WFQz2E Update 4 https://t.co/PLmgI55sUF #neuropath #uscap2019 #directfromthesource
RT @mlage: Update 1 https://t.co/gHPtjeksjh Update 2 https://t.co/Mdqme1wZs3 Update 3 https://t.co/9Qfaj4B7Bh Update 4 https://t.co/c62jqda…
RT @mlage: Update 1 https://t.co/gHPtjeksjh Update 2 https://t.co/Mdqme1wZs3 Update 3 https://t.co/9Qfaj4B7Bh Update 4 https://t.co/c62jqda…
RT @mlage: Update 1 https://t.co/gHPtjeksjh Update 2 https://t.co/Mdqme1wZs3 Update 3 https://t.co/9Qfaj4B7Bh Update 4 https://t.co/c62jqda…
RT @mlage: Update 1 https://t.co/gHPtjeksjh Update 2 https://t.co/Mdqme1wZs3 Update 3 https://t.co/9Qfaj4B7Bh Update 4 https://t.co/c62jqda…
RT @mlage: Update 1 https://t.co/gHPtjeksjh Update 2 https://t.co/Mdqme1wZs3 Update 3 https://t.co/9Qfaj4B7Bh Update 4 https://t.co/c62jqda…
RT @mlage: Update 1 https://t.co/gHPtjeksjh Update 2 https://t.co/Mdqme1wZs3 Update 3 https://t.co/9Qfaj4B7Bh Update 4 https://t.co/c62jqda…
RT @mlage: Update 1 https://t.co/gHPtjeksjh Update 2 https://t.co/Mdqme1wZs3 Update 3 https://t.co/9Qfaj4B7Bh Update 4 https://t.co/c62jqda…
RT @mlage: Update 1 https://t.co/gHPtjeksjh Update 2 https://t.co/Mdqme1wZs3 Update 3 https://t.co/9Qfaj4B7Bh Update 4 https://t.co/c62jqda…
RT @mlage: Update 1 https://t.co/gHPtjeksjh Update 2 https://t.co/Mdqme1wZs3 Update 3 https://t.co/9Qfaj4B7Bh Update 4 https://t.co/c62jqda…
RT @mlage: Update 1 https://t.co/gHPtjeksjh Update 2 https://t.co/Mdqme1wZs3 Update 3 https://t.co/9Qfaj4B7Bh Update 4 https://t.co/c62jqda…
RT @mlage: Update 1 https://t.co/gHPtjeksjh Update 2 https://t.co/Mdqme1wZs3 Update 3 https://t.co/9Qfaj4B7Bh Update 4 https://t.co/c62jqda…
RT @mlage: Update 1 https://t.co/gHPtjeksjh Update 2 https://t.co/Mdqme1wZs3 Update 3 https://t.co/9Qfaj4B7Bh Update 4 https://t.co/c62jqda…
Update 1 https://t.co/gHPtjeksjh Update 2 https://t.co/Mdqme1wZs3 Update 3 https://t.co/9Qfaj4B7Bh Update 4 https://t.co/c62jqdazHa #neuropath #uscap2019 #directfromthesource
RT @NeuropathClinic: "cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular fe…
RT @radonconeuro: @mlage @CraigHorbinski @DrTomJacques @neuropathobern @kriyer68 #newupdatesneuroonc #IDH #neuropath #gliomas cIMPACT-NOW u…
RT @BrainTumorInst: In the third cIMPACT-NOW update, @DanielJBrat, @roger_stupp and a multi-institutional team outline diagnostic criteria…
RT @BrainTumorInst: In the third cIMPACT-NOW update, @DanielJBrat, @roger_stupp and a multi-institutional team outline diagnostic criteria…
RT @BrainTumorInst: In the third cIMPACT-NOW update, @DanielJBrat, @roger_stupp and a multi-institutional team outline diagnostic criteria…
RT @BrainTumorInst: In the third cIMPACT-NOW update, @DanielJBrat, @roger_stupp and a multi-institutional team outline diagnostic criteria…
In the third cIMPACT-NOW update, @DanielJBrat, @roger_stupp and a multi-institutional team outline diagnostic criteria for diffuse astrocytic #glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV. New in Acta Neuropathologica: http
RT @NeuropathClinic: "cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular fe…
RT @NeuropathClinic: "cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular fe…
RT @NeuropathClinic: "cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular fe…
RT @NeuropathClinic: "cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular fe…
RT @NeuropathClinic: "cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular fe…
RT @radonconeuro: @mlage @CraigHorbinski @DrTomJacques @neuropathobern @kriyer68 #newupdatesneuroonc #IDH #neuropath #gliomas cIMPACT-NOW u…
RT @NeuropathClinic: "cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular fe…
RT @NeuropathClinic: "cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular fe…
RT @NeuropathClinic: "cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular fe…
RT @NeuropathClinic: "cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular fe…
RT @NeuropathClinic: "cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular fe…
RT @NeuropathClinic: "cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular fe…
"cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”" https://t.co/B4nKYwYJ71 #neuropath
RT @radonconeuro: @mlage @CraigHorbinski @DrTomJacques @neuropathobern @kriyer68 #newupdatesneuroonc #IDH #neuropath #gliomas cIMPACT-NOW u…
RT @radonconeuro: @mlage @CraigHorbinski @DrTomJacques @neuropathobern @kriyer68 #newupdatesneuroonc #IDH #neuropath #gliomas cIMPACT-NOW u…
@mlage @CraigHorbinski @DrTomJacques @neuropathobern @kriyer68 #newupdatesneuroonc #IDH #neuropath #gliomas cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO g…